title: Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results.
abstract: OBJECTIVE
  The multicenter EPIC (FiberNet Embolic Protection System in Carotid Artery Stenting Trial) single-arm trial evaluated the 30-day outcomes of a new design concept for embolic protection during carotid artery stenting (CAS).
  
  
  BACKGROUND
  Embolic protection filters available for use during CAS include fixed and over-the-wire systems that rely on embolic material capture within a "basket" structure. The FiberNet Embolic Protection System (EPS), which features a very low crossing profile, consists of a three-dimensional fiber-based filter distally mounted on a 0.014 inch guidewire with integrated aspiration during filter retrieval.
  
  
  METHODS
  The trial enrolled 237 patients from 26 centers. Demographics, clinical and lesion characteristics, as well as adverse events through a 30-day follow-up were recorded. The mean age of the patients was 74 years, 64% were male and 20% had symptomatic carotid artery disease.
  
  
  RESULTS
  The combined major adverse event (MAE) rate at 30 days for all death, stroke, and myocardial infarction was 3.0%. There were three major strokes (two ischemic and one hemorrhagic) and two minor strokes (both ischemic) for a 2.1% 30-day stroke rate. The procedural technical success rate was 97.5% and macroscopic evidence of debris was reported in 90.9% of the procedures.
  
  
  CONCLUSIONS
  The FiberNet EPS, used with commercially available stents, produced low stroke rates following CAS in high surgical risk patients presenting with carotid artery disease. The unique filter design including aspiration during retrieval may have contributed to the low 30-day stroke rate reported during CAS in patients considered at high risk for complications following carotid endarterectomy (CEA).
authors.affiliation: Hoag Memorial Hospital, Newport Beach, California 92663, USA. subbaraomyla@gmail.com
authors.forename: Subbarao
authors.initials: S
authors.lastname: Myla
authors.forename: J Michael
authors.initials: JM
authors.lastname: Bacharach
authors.forename: Gary M
authors.initials: GM
authors.lastname: Ansel
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Dippel
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: McCormick
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Popma
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000800:Angioplasty, Balloon / Q000295:instrumentation*; D016893:Carotid Stenosis / Q000628:therapy*; D002560:Cerebrovascular Circulation; D002986:Clinical Trials as Topic; D020878:Device Removal; D005260:Female; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D020766:Intracranial Embolism / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D015607:Stents; D020521:Stroke / Q000517:prevention & control